Sara Gredmark Russ group - Viruses and their interactions with the immune system
The research in our group lies within the area of immunology, with the main focus on viruses and their interactions with the immune system.
Viral infections can cause a number of different acute and chronic conditions. The approaches to treat these conditions are limited, and for many viral infections, there are no alternatives at all. Our research focuses on advancing the knowledge in the basic principles of the immune response to viral infections in humans. Our long-term goal is, aside from gaining knowledge in the basic functions of the human immune system, to contribute to the development of new diagnostics, treatment, and vaccination strategies for viral infections.
One of the main subjects of our research is tick-borne encephalitis virus (TBEV). TBEV is a member of the flavivirus family, and is transferred to humans from ticks. TBEV is the causative agent of tick-borne encephalitis (TBE). One major problem with TBE is the risk for long lasting neurological sequele. TBE is an emerging disease and has become a growing health challenge in endemic areas, with as many cases as up to 10 000 per year globally. The only effective protection against TBE is properly timed vaccination, before the exposure to TBEV-infected ticks. Despite the fact that vaccination against TBE is increasing in the at-risk population in Sweden, the numbers of patients suffering from TBE have also been increasing over the last decade. In addition, over the last years a number of vaccine failures have been reported. It is believed that the true number of vaccine failures may be underestimated due to the difficulties in distinguishing between serological responses elicited by vaccination and natural infection.
Even though TBE has become an important public health concern, the underlying basis for the development of encephalitis in TBEV infection remains undefined, and there are only a few studies addressing the mechanism of disease development.
Sara Gredmark RussGroup Leader, MD, PhD
Medical Doctor, Karolinska Institutet, 2001. PhD in Experimental medicine, Center for Molecular Medicine, KI, 2005, working in the area of immunology and virology. Post Doctoral fellow, in the laboratory of Hidde Ploegh, at the Whitehead Institute at MIT 2005-2008, working with immunology, biochemistry and virology. Associated professor at Karolinska Institutet since 2019 and Infectious Diseases Doctor at the Infectious Disease Clinic at the Karolinska University Hospital.
Renata VarnaiteDoctoral Student, MSci
Renata obtained her MSci degree in Biochemistry from the University of St Andrews before moving to Sweden. Her degree involved a 1-year-long research placement at the laboratory of Jonathan Stoye at Francis Crick Institute, London where she studied evolution of antiretroviral gene Fv1. During her Master’s project Renata focused on developing a DNA vaccine against Foot and Mouth Disease Virus at Martin Ryan lab in St Andrews. She continues her education in virology and immunology at Karolinska Institutet since 2016 with the focus on human immune system responses to tick-borne encephalitis virus infection.
We always want to get in touch with talented potential co-workers. If you are interested in doing research within our group, as a degree project or as a researcher, please contact the Group leader Sara Gredmark Russ.
Characterization of the immune response during the natural course of tick-borne encephalitis virus (TBEV) infection in humans
In this project, we utilize advanced flow cytometry and other immunology methods, in order to characterize the kinetics and profile of innate and adaptive immune responses during TBE disease and TBE vaccination. Our overall goal is to translate our findings for the improvement of diagnostic tools, vaccine strategies and treatment of patients.
Identification of human cellular proteins and factors required for TBEV entry and replication
This project aims to identify human cellular proteins that are essential for TBEV infection, which could serve as novel therapeutic targets for TBE treatment. We utilise a genome-wide haploid genetic screen, a cutting-edge technology that allows rapid and sensitive identification of host factors utilised by pathogens for their entry and replication. This technique will be combined with deep sequencing and advanced bioinformatics analysis to identify host proteins needed for TBEV infection.
Immune cells in the central nervous system during viral infections
In healthy conditions, lymphocytic trafficking into the CNS is tightly controlled by the blood brain-barrier (BBB), but under inflammatory conditions, circulating lymphocytes and monocytes/macrophages can cross the BBB easily and gain access to CNS compartments, potentially leading to pathology. This project aims to characterize the infiltrating immune cell subsets within the cerebrospinal fluid and compare the subsets with peripheral blood. Additionally, we utilize in vitro BBB models to study the transmigration capability of immune cells during neurotropic viral infections.
Characterization of the immune response during SARS-CoV-2 (COVID-19) infection in humans
Recently, with the first case in 2019, SARS-Cov-2 (COVID-19), has emerged, causing severe respiratory disease and having a significant burden on the health care system. We have set up a similar approach as for TBE to study SARS-Cov-2 in order to characterize the kinetics and profile of the adaptive immune responses during COVID-19 infection.
virus, infection, T cells, immunology, host response, central nervous system
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R, García M, Glans H, Maleki KT, Sandberg JT, Tynell J, et al
J Immunol 2020 11;205(9):2437-2446
Magnitude and Functional Profile of the Human CD4+ T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus Vaccine.
Varnaitė R, Blom K, Lampen MH, Vene S, Thunberg S, Lindquist L, et al
J Immunol 2020 02;204(4):914-922
Tick-borne Encephalitis Vaccine Failures: A 10-year Retrospective Study Supporting the Rationale for Adding an Extra Priming Dose in Individuals Starting at Age 50 Years.
Hansson KE, Rosdahl A, Insulander M, Vene S, Lindquist L, Gredmark-Russ S, et al
Clin Infect Dis 2020 01;70(2):245-251
Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8+ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection.
Lampen MH, Uchtenhagen H, Blom K, Varnaitė R, Pakalniene J, Dailidyte L, et al
Immunohorizons 2018 07;2(6):172-184
NK Cell Responses to Human Tick-Borne Encephalitis Virus Infection.
Blom K, Braun M, Pakalniene J, Lunemann S, Enqvist M, Dailidyte L, et al
J Immunol 2016 10;197(7):2762-71
Specificity and dynamics of effector and memory CD8 T cell responses in human tick-borne encephalitis virus infection.
Blom K, Braun M, Pakalniene J, Dailidyte L, Béziat V, Lampen MH, et al
PLoS Pathog 2015 Jan;11(1):e1004622